Antibiotic Resistant Bloodstream Infections in Pediatric Patients Receiving Chemotherapy or Hematopoietic Stem Cell Transplant: Factors Associated with Development of Resistance, Intensive Care Admission and Mortality

• Ngā kaituhi matua: Elio Castagnola (Author), Francesca Bagnasco (Author), Alessio Mesini (Author), Philipp K. A. Agyeman (Author), Roland A. Ammann (Author), Fabianne Carlesse (Author), Maria Elena Santolaya de Pablo (Author), Andreas H. Groll (Author), Gabrielle M. Haeusler (Author), Thomas Lehrnbecher (Author), Arne Simon (Author), Maria Rosaria D'Amico (Author), Austin Duong (Author), Evgeny A. Idelevich (Author), Marie Luckowitsch (Author), Mariaclaudia Meli (Author), Giuseppe Menna (Author), Sasha Palmert (Author), Giovanna Russo (Author), Marco Sarno (Author), Galina Solopova (Author), Annalisa Tondo (Author), Yona Traubici (Author), Lillian Sung (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2021-03-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Bloodstream infections (BSI) are a severe complication of antineoplastic chemotherapy or hematopoietic stem cell transplantation (HSCT), especially in the presence of antibiotic resistance (AR). A multinational, multicenter retrospective study in patients aged ≤ 18 years, treated with chemotherapy o...